5 Amendments of Sari ESSAYAH related to 2012/0169(COD)
Amendment 174 #
Proposal for a regulation
Article 2 – paragraph 2 – point a
Article 2 – paragraph 2 – point a
(a) life insurance products, which do not offer a surrender value or where that surrender value is not wholly or partially exposed, directly or indirectly, to market fluctuationsith or without profit sharing, where the investment risk is not borne by the policyholder and which fall under Annex I (I) of Directive 2002/83/EC and annex II (I) of Directive 2009/138/EC;
Amendment 347 #
Proposal for a regulation
Article 8 – paragraph 2 – point c – introductory part
Article 8 – paragraph 2 – point c – introductory part
(c) under a section titled ‘Could I lose money?’"Level of Capital Protection", a brief indication of whether loss of capital is possible, including
Amendment 370 #
Proposal for a regulation
Article 8 – paragraph 2 – point d
Article 8 – paragraph 2 – point d
(d) under a section titled ‘What is it for?’"Objectives and investment policy" an indication of the recommended minimum holding period and the expected liquidity profile of the product including the possibility and conditions for any disinvestments before maturity, having regard to the risk and reward profile of the investment product and the market evolution it targets;
Amendment 376 #
Proposal for a regulation
Article 8 – paragraph 2 – point e
Article 8 – paragraph 2 – point e
(e) under a section titled ‘What are the r"Risks and what might I get back?’reward profile", the risk and reward profile of the investment product, including a summary indicator of this profile and warnings in relation to any specific risks that may not be fu, its main limitations and a narrative explanation of the risks which are materially reflected in the summary indicator;vant to the PRIP and which are not adequately captured by summary indicator of the risk and reward profile.
Amendment 496 #
Proposal for a regulation
Article 11 – paragraph 2
Article 11 – paragraph 2
2. When a retail investor demonstrates a loss resulting from the use of the information contained in the key information document, the investment product manufacturer shas to prove that the key information document has been drawn up in compliance with Articles 6, 7 and 8 of this Regulationll not incur civil liability solely on the basis of the key information document, including any translation thereof, unless it is misleading, inaccurate or inconsistent with other binding contractual documents. The key information document shall contain a clear warning in this respect.